Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nafamostat is expected to prevent the transmission of new coronavirus infection (COVID-19)

worldpharmanewsMarch 31, 2020

Tag: SARS-CoV-2 , Nafamostat , COVID-19

PharmaSources Customer Service